This section of the site includes press releases and statements issued by the MHRA.
The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.
The Press Office
5th Floor
151 Buckingham Palace Road
Victoria
LONDON
SW1W 9SZ
Main telephone: 020 3080 7651
Out of hours: 07770 446 189
press.office@mhra.gsi.gov.uk
For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.
We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time.
Follow @MHRApress
Press enquiries should be made through the Press Office.
Latest press releases
-
14 Jun 2013 | Press statement: MHRA responds to European Medicines Agency recommendation on codeine
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency has recommended that codeine-containing medicines should only be used in children over 12 years old to treat acute (short lived) moderate pain, and only if it cannot be relieved by other painkillers such as paracetamol or ibuprofen.
-
12 Jun 2013 | Press release: UK moves towards safe and effective electronic cigarettes and other nicotine-containing products
All nicotine-containing products (NCPs), such as electronic cigarettes, are to be regulated as medicines in a move to make these products safer and more effective to reduce the harms of smoking.
-
12 Jun 2013 | Press release: Recall of some batches of Ventolin Syrup
The MHRA have today issued a drug alert to healthcare professionals advising them on the recall of two batches of Ventolin Syrup sugar-free 2mg in 5ml manufactured by Glaxo Wellcome UK Ltd, trading as Allen & Hanburys.
-
06 Jun 2013 | Press release: New tracking system for high-risk medical devices in development as the MHRA responds to review on PIP breast implants scandal
The Medicines and Healthcare products Regulatory Agency (MHRA) today announced that four NHS trusts have committed to piloting a new tracking system for high risk medical devices that will improve the monitoring of medical devices such as breast implants, heart valves and pacemakers
-
30 May 2013 | MHRA responds to European Medicines Agency review on Dianette
Dr Sarah Branch, the MHRA’s Deputy Director for Vigilance and Risk Management of Medicines, said:
-
23 May 2013 | Press release: Re-appointment to Agency Board
The Medicines and Healthcare Products Regulatory Agency today announced the re-appointment of Mr. John Williams CBE as a non-executive director of the Agency Board.
-
01 May 2013 | Press release: MHRA issues warning about FreeStyle InsuLinx blood glucose meter
The MHRA today issued a warning to people with diabetes about a software fault in a specific blood glucose meter. This could give an incorrect low result in the rare event that the blood glucose level is extremely high.
-
23 Apr 2013 | Press release: Over £500,000 of unlicensed sex, diet and hair loss drugs seized in a west London raid
A haul netting more than half a million pounds of unlicensed sex, diet and hair loss drugs was seized by the Medicines and Healthcare products Regulatory Agency (MHRA) in a west London raid.
-
17 Apr 2013 | Press release: Man jailed in pre-clinical trial data scam case
A man was sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.
-
17 Apr 2013 | Press release: Warning over potentially toxic Chinese herbal medicine
The MHRA is warning people not to use a particular Chinese herbal medicine, used to treat migraines, as it contains a potentially toxic herbal ingredient.
